How much IV fluid is too much? lung scans put surgical fluid levels to the test
NCT ID NCT06104020
First seen Sep 16, 2026 · Last updated Sep 17, 2026 · Updated 1 time
Summary
Researchers at Assiut University are comparing two intravenous fluid strategies during shoulder arthroscopy: a restrictive approach that aims for net zero fluid balance and a liberal approach that gives more fluid. They will use lung ultrasound to look for postoperative pulmonary complications and track blood pressure, heart rate, oxygen levels, and vasopressor use. The trial enrolls 60 adults scheduled for elective shoulder arthroscopy to see which fluid strategy better protects the lungs and keeps circulation stable.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- intraoperative fluid management strategies (restrictive versus liberal intravenous fluids)
- What this could lead to
- If one fluid approach proves safer, it could shape how anesthesiologists manage IV fluids during shoulder arthroscopy to lower the risk of breathing problems after surgery.
- What could go wrong
- This is a small single-center study of 60 people, so its results may not apply to other hospitals or patients with different health profiles. Lung ultrasound scores are an indirect measure, and fluid shifts during surgery can be hard to control.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Nov 2024
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients scheduled for elective shoulder arthroscopic surgery. * Adults aged 18 years and above. * Capable of providing informed consent voluntarily. * No known allergies or sensitivities to substances commonly used in the surgical procedure or study. * Stable baseline hemodynamics during preoperative evaluation Exclusion Criteria: * Patients scheduled for open shoulder surgery. * Medical Comorbidities: * Pulmonary diseases, including chronic pulmonary diseases or pulmonary edema. * Previous cardiac diseases such as heart failure, myocardial infarction (MI), hypertension, and known types of arrhythmia. * Severe Organ Disease: Severe liver or kidney disease. * Body mass index (BMI) ≥ 35 kg/m². * Abnormal coagulation function. * Pregnancy * Refusal to Participate or Patients who cannot provide informed consent due to cognitive impairment or other reasons. * Previous shoulder arthroscopy.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Shoulder arthropathy associated with other conditions are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assuit university
Asyut, Egypt